ACE2 and COVID-19: Further, it is interesting that the association between plasma ACE2 and maximal acuity within 28 days in COVID-19 patients was statistically significant also after correction for age, BMI, pre-existing medical conditions, and the laboratory tests CRP, absolute neutrophil count and D-dimer.